EUVIMEDEUVIMED entdecken
Crossref

Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life

Karen Lynch

The American Journal of Managed Care · 2023

DOI: 10.37765/ajmc.2023.89389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Managed Care, 2023. Verfasst von Karen Lynch. Beteiligte Einrichtung: Physician and neurologist at Neurologists of Cape Cod, Cape Cod Healthcare, in Hyannis, MA. Email: kmlynch@capecodhealth.org. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHumansQuality of LifeRiluzoleEdaravonePhenylbutyrates

Substanzen

RiluzoleEdaravonesodium phenylbutyrate and taurursodiolPhenylbutyrates

Autor:innen und Institutionen

  • Physician and neurologist at Neurologists of Cape Cod, Cape Cod Healthcare, in Hyannis, MA. Email: kmlynch@capecodhealth.org.

Zitieren

APA

Lynch, K. (2023). Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2023.89389

Vancouver

Lynch K. Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life. The American Journal of Managed Care. 2023. doi:10.37765/ajmc.2023.89389

BibTeX
@article{Lynch2023,
  author = {Lynch, Karen},
  title = {Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life},
  journal = {The American Journal of Managed Care},
  year = {2023},
  doi = {10.37765/ajmc.2023.89389}
}
Kostenlos starten →